These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3390804

  • 1. Tumor induction in mice administered neonatally with 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole or 2-amino-dipyrido[1,2-a:3',2'-d]imidazole.
    Fujii K, Sakai A, Nomoto K, Nakamura K.
    Cancer Lett; 1988 Jul; 41(1):75-80. PubMed ID: 3390804
    [Abstract] [Full Text] [Related]

  • 2. Tumor induction in mice administered neonatally with 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole or 3-amino-1-methyl-5H-pyrido[4,3-b]indole.
    Fujii K, Nomoto K, Nakamura K.
    Carcinogenesis; 1987 Nov; 8(11):1721-3. PubMed ID: 3664965
    [Abstract] [Full Text] [Related]

  • 3. Tumor induction in mice administered neonatally with 1,2-dimethylhydrazine.
    Fujii K, Komano H.
    Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):46-50. PubMed ID: 2640067
    [Abstract] [Full Text] [Related]

  • 4. Carcinogenicity in mice of mutagenic compounds from glutamic acid and soybean globulin pyrolysates.
    Ohgaki H, Matsukura N, Morino K, Kawachi T, Sugimura T, Takayama S.
    Carcinogenesis; 1984 Jun; 5(6):815-9. PubMed ID: 6539177
    [Abstract] [Full Text] [Related]

  • 5. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse.
    Dooley KL, Von Tungeln LS, Bucci T, Fu PP, Kadlubar FF.
    Cancer Lett; 1992 Mar 15; 62(3):205-9. PubMed ID: 1596864
    [Abstract] [Full Text] [Related]

  • 6. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450.
    Ishii K, Yamazoe Y, Kamataki T, Kato R.
    Chem Biol Interact; 1981 Dec 15; 38(1):1-13. PubMed ID: 6120046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intestinal tumors in rats induced by mutagens from glutamic acid pyrolysate.
    Masuda M, Takayama S.
    Exp Pathol; 1984 Dec 15; 26(3):123-9. PubMed ID: 6097472
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M, Hasegawa R, Kimura J, Akagi K, Yoshida Y, Tanaka H, Miki T, Satoh T, Wakabayashi K, Ito N.
    Carcinogenesis; 1995 Dec 15; 16(12):3049-55. PubMed ID: 8603484
    [Abstract] [Full Text] [Related]

  • 12. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods.
    Ohgaki H, Hasegawa H, Suenaga M, Sato S, Takayama S, Sugimura T.
    Carcinogenesis; 1987 May 15; 8(5):665-8. PubMed ID: 3581424
    [Abstract] [Full Text] [Related]

  • 13. Strong inhibition of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone.
    Hirose M, Akagi K, Hasegawa R, Satoh T, Nihro Y, Miki T, Sugimura T, Ito N.
    Jpn J Cancer Res; 1993 May 15; 84(5):481-4. PubMed ID: 8320163
    [Abstract] [Full Text] [Related]

  • 14. Chemical modification of DNA with muta-carcinogens. I. 3-Amino-1-methyl-5H-pyrido[4,3-b]indole and 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole: metabolic activation and structure of the DNA adducts.
    Hashimoto Y, Shudo K.
    Environ Health Perspect; 1985 Oct 15; 62():209-14. PubMed ID: 4085425
    [Abstract] [Full Text] [Related]

  • 15. Induction of cancers in the intestine, liver and various other organs of rats by feeding mutagens from glutamic acid pyrolysate.
    Takayama S, Masuda M, Mogami M, Ohgaki H, Sato S, Sugimura T.
    Gan; 1984 Mar 15; 75(3):207-13. PubMed ID: 6144612
    [Abstract] [Full Text] [Related]

  • 16. [DNA modification and carcinogenesis--early events caused by a heterocyclic aromatic amine, Glu-P-1].
    Shudo K, Hashimoto Y.
    Gan To Kagaku Ryoho; 1989 Mar 15; 16(3 Pt 2):445-50. PubMed ID: 2650626
    [Abstract] [Full Text] [Related]

  • 17. Chemical modification of DNA with muta-carcinogens. II. Base sequence-specific binding to DNA of 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1).
    Hashimoto Y, Shudo K.
    Environ Health Perspect; 1985 Oct 15; 62():215-8. PubMed ID: 3910418
    [Abstract] [Full Text] [Related]

  • 18. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
    Hirose M, Iwata S, Ito E, Nihro Y, Takahashi S, Mizoguchi Y, Miki T, Satoh T, Ito N, Shirai T.
    Carcinogenesis; 1995 Sep 15; 16(9):2227-32. PubMed ID: 7554080
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion levels of carcinogenic glutamic acid pyrolysis products and their N-acetyl derivatives in humans.
    Kanai Y, Wada O, Manabe S.
    Nihon Eiseigaku Zasshi; 1991 Oct 15; 46(4):922-9. PubMed ID: 1684216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.